Overview of Acetyl Hexapeptide-8
Acetyl Hexapeptide-8 is a fully synthetic peptide composed of six amino acids arranged in the precise sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-NH₂ (Ac-EEMQRR-NH₂). The Chemical Abstracts Service (CAS) registry number for this compound is 616204-22-9, and its molecular formula is C₃₄H₆₀N₁₄O₁₂S with a monoisotopic mass of approximately 888.9 Daltons. The peptide is N-terminally acetylated and C-terminally amidated, modifications that enhance its stability in laboratory environments.
In research settings, Acetyl Hexapeptide-8 is employed as a tool to study intracellular protein trafficking, specifically the formation of the SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex. Solid-phase synthesis routinely yields material with high batch-to-batch consistency, making it valuable for reproducible in vitro assays. The peptide is classified as a research chemical and is intended strictly for laboratory experimentation; it is not for human or veterinary use.
Importance of GMP in Peptide Manufacturing
Good Manufacturing Practices (GMP) constitute a quality-assurance framework that ensures every step of production—from raw material receipt to final packaging—is controlled, documented, and validated. For peptides like Acetyl Hexapeptide-8, adherence to GMP principles is the recognized international standard for delivering materials that meet the stringent demands of academic and industrial research.
GMP-manufactured peptides help research institutions minimize experimental variability. Each batch is produced under defined parameters, reducing the risk of introducing impurities that could confound cell-based assays or binding studies. Rigorous process controls, validated cleaning procedures, and comprehensive record‑keeping form the backbone of a reliable B2B supply chain for research-grade peptides.
What is GMP?
GMP is a system of standards developed and enforced by regulatory agencies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Health Organization (WHO). It covers the entire production lifecycle:
- Raw materials: Qualification and testing of all incoming amino acids, resins, and solvents.
- Facilities and equipment: Controlled environments with HVAC filtration, calibrated instruments, and validated cleaning cycles.
- Personnel: Ongoing training and hygiene protocols to prevent contamination.
- Documentation: Batch records, standard operating procedures, and deviation reports that ensure full traceability.
Compliance with GMP is assessed through regular audits, and a manufacturer’s adherence signals to research partners that the peptide is produced under conditions equivalent to those applied in pharmaceutical development.
Why GMP Matters for Research Peptides
For Acetyl Hexapeptide-8 destined for preclinical and mechanistic studies, GMP manufacturing offers several critical advantages:
- High purity (≥98%): GMP processes employ preparative HPLC purification and analytical verification, removing synthesis‑related impurities that could interfere with receptor‑binding or enzyme‑activity assays.
- Full traceability: Comprehensive batch records, from lot‑controlled amino acid derivatives to final release dates, allow researchers to trace any result back to the source material, supporting data integrity and audit readiness.
- Reproducibility: Validated manufacturing workflows minimize batch‑to‑batch variability, enabling multi‑site research collaborations to generate consistent data over time.
- Regulatory alignment: While research‑grade peptides are not intended for therapeutic use, GMP-produced material simplifies later technology transfer should a compound progress toward investigational stages.
Our GMP Manufacturing Process
We operate a GMP‑certified peptide synthesis facility where every stage—from amino acid procurement to final lyophilization—follows internationally harmonized guidelines. Our quality unit releases a batch only after all in‑process checks and final analytical tests have passed predefined specifications. Production takes place in dedicated cleanroom suites with ISO‑classified areas to prevent cross‑contamination between peptide projects.
Solid-Phase Peptide Synthesis (SPPS)
Acetyl Hexapeptide-8 is constructed using Fmoc‑based solid‑phase peptide synthesis (SPPS), the industry‑standard methodology that allows stepwise, high‑efficiency assembly of the peptide chain:
- Resin loading: A Rink amide resin is selected to yield the C‑terminal amide upon cleavage.
- Deprotection: The N‑terminal Fmoc group is removed with a mild base while the side‑chain protecting groups remain intact.
- Coupling: Each activated Fmoc‑protected amino acid (Glu(OtBu), Gln(Trt), Arg(Pbf), Met) is coupled using a coupling‑reagent system optimized for the specific sequence. Monitoring via Kaiser test or conductivity ensures quantitative coupling at each step.
- Cleavage and global deprotection: A cocktail containing trifluoroacetic acid (TFA), scavengers, and water cleaves the peptide from the resin and removes side‑chain protecting groups simultaneously.
Automated peptide synthesizers with pre‑programmed protocols minimize manual handling errors, while real‑time UV monitoring of deprotection steps provides a record of coupling efficiency for each residue.
Purification and Analysis
The crude peptide undergoes a multi‑stage purification and characterization workflow to meet the ≥98% purity specification:
- Preparative reverse‑phase HPLC: The target peptide is separated from deletion sequences, truncated fragments, and diastereomers using a C18 column with an optimized water‑acetonitrile gradient containing 0.1% TFA.
- Analytical HPLC purity check: Purified fractions are pooled based on analytical HPLC chromatograms; the final product is reinjected on an analytical system to confirm a single main peak at ≥98% area under 214 nm detection.
- Mass spectrometry: Electrospray ionization mass spectrometry (ESI‑MS) or matrix‑assisted laser desorption/ionization (MALDI‑TOF) verifies the molecular weight within ±1 Da of the theoretical mass.
- Additional tests: Amino acid analysis (AAA) confirms the correct stoichiometric composition, peptide content (net peptide weight) is determined by nitrogen analysis or quantitative amino acid analysis, and residual solvent levels are measured by gas chromatography to ensure they fall below ICH Q3C limits.
Quality Assurance and Certifications
Our GMP compliance is verified through periodic inspections by recognized third‑party auditing bodies. The quality management system embraces ICH Q7 (Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients) and WHO GMP principles, tailored to the production of research‑grade peptides. Key elements of our quality assurance program include:
- Validated processes: All critical equipment—HPLC systems, lyophilizers, balances—undergoes installation, operational, and performance qualification.
- Environmental monitoring: Cleanroom particle counts, microbial levels, and pressure differentials are continuously monitored.
- Batch release documentation: Every shipment of Acetyl Hexapeptide-8 includes a Certificate of Analysis (COA) that details the batch number, appearance, purity by HPLC, molecular weight determination, peptide content, and expiry date.
- Safety information: A Material Safety Data Sheet (MSDS or SDS) is provided, covering handling, storage (typically at -20°C as a lyophilized powder), and emergency measures for laboratory personnel.
Applications in Research
Acetyl Hexapeptide-8 is a versatile molecular probe in cell biology and biochemistry laboratories. All uses are confined to in vitro investigations:
- SNARE complex studies: The peptide’s sequence mimics part of the SNAP‑25 protein and has been shown in published literature to inhibit SNARE‑dependent vesicle docking and neurotransmitter release in neuronal cell models. This makes it a tool for investigating exocytosis mechanisms.
- Receptor‑binding assays: Researchers use labeled or unlabeled Acetyl Hexapeptide-8 to characterize peptide‑receptor interactions, binding kinetics, and competitive displacement in cell‑free systems or cultured cells.
- Signal transduction research: In cell‑based assays, the peptide helps dissect pathways dependent on Ca²⁺‑triggered membrane fusion or downstream signaling modulated by SNARE proteins.
- Controls for peptidomimetic design: The well‑defined structure serves as a reference compound in structure‑activity relationship (SAR) campaigns aimed at designing more stable or selective peptide analogs.
Partnering with a Trusted Manufacturer
We support research organizations and distributors with tailored services that go beyond the supply of catalogue peptides:
- Flexible packaging: Quantities range from 5 mg for pilot experiments to 100 g and above for large‑scale in vitro programs, all filled in inert‑atmosphere vials under GMP controls.
- Custom synthesis: Our SPPS capability allows for rapid production of acetyl‑ or other N‑terminal‑modified analogs, isotope‑labeled (e.g., ¹³C/¹⁵N) peptides, or peptide‑linker conjugates that meet specific research needs.
- Global logistics: All shipments are handled with temperature‑controlled packaging (cool packs or insulated containers) to preserve peptide stability during transit. Full customs documentation and import support are provided.
- Technical support: Our scientific team offers guidance on peptide solubilization, storage, and assay design, as well as regulatory documentation (Drug Master Files type‑equivalent summary, upon request) to ease the integration into your research workflow.
Frequently Asked Questions
What is the typical purity of Acetyl Hexapeptide-8?
Our standard catalogue specification is ≥98% purity as measured by reverse‑phase analytical HPLC at 214 nm. Upon request and with additional preparative steps, we can deliver material with >99% chromatographic purity. Each COA reports the exact purity for that batch.
Do you provide documentation for research use?
Yes. Every shipment is accompanied by a Certificate of Analysis (COA) detailing appearance, purity, mass spectrometry data, peptide content, and storage conditions. A Material Safety Data Sheet (MSDS) is also included to ensure safe handling and disposal in your laboratory.
Can you scale up production for research needs?
Absolutely. Our GMP‑compliant suites can handle syntheses from laboratory‑scale (100 mg) to multi‑gram batches. For long‑term research collaborations, we offer reserved‑batch manufacturing to ensure a single, fully characterized lot serves an entire project, eliminating inter‑batch variability.
Contact Us for Research-Grade Acetyl Hexapeptide-8
When you require a reliable Acetyl Hexapeptide-8 GMP manufacturer, our team is prepared to discuss your specifications, provide batch‑specific analytical data, and issue a quotation. Use our online inquiry portal, and we will respond within one business day with comprehensive technical and commercial details.
Partner with a GMP‑certified synthesis facility that prioritizes the quality, traceability, and consistency essential for rigorous research. Our peptides are produced exclusively for laboratory investigation and are backed by the documentation and support your team expects.
Note: All products, including Acetyl Hexapeptide-8, are intended strictly for laboratory research use. They are not approved for human or veterinary clinical applications, therapeutics, or diagnostics. Regulatory approvals (e.g., FDA, EMA) have not been obtained for any diagnostic, therapeutic, or food‑related use. Purchasers are responsible for confirming that their intended use complies with all applicable laws and regulations.
For research use only. Not for human or veterinary use.
